Resultats de la cerca - Arshad Mujeebuddin

  • Mostrar 1 - 2 resultats de 2
Refinar resultats
  1. 1
    Eculizumab in paroxysmal nocturnal haemoglobinuria and atypical haemolytic uraemic syndrome: 10‐year pharmacovigilance analysis

    Eculizumab in paroxysmal nocturnal haemoglobinuria and atypical haemolytic uraemic syndrome: 10‐year pharmacovigilance analysis per Gèrard Socié, Marie‐Pierre Caby‐Tosi, Jing L. Marantz, Alexander J. Cole, Camille L. Bedrosian, Christoph Gasteyger, Arshad Mujeebuddin, Peter Hillmen, Johan Vande Walle, Hermann Haller

    Publicat 2019
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  2. 2
    Long‐term safety and efficacy of ravulizumab in patients with paroxysmal nocturnal hemoglobinuria: 2‐year results from two pivotal phase 3 studies

    Long‐term safety and efficacy of ravulizumab in patients with paroxysmal nocturnal hemoglobinuria: 2‐year results from two pivotal phase 3 studies per Austin Kulasekararaj, Morag Griffin, Saskia Langemeijer, Kensuke Usuki, Alexander Kulagin, Masayo Ogawa, Ji Yu, Arshad Mujeebuddin, Jun‐ichi Nishimura, Jong Wook Lee, Régis Peffault de Latour

    Publicat 2022
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: